台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    45.85
  • 漲跌
    ▲0.45
  • 漲幅
    +0.99%
  • 成交量
    122
  • 產業
    上市 生技醫療類股
  • 126人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
和康生 (1783)籌碼相關-統一-士林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0404/2005/0405/1805/3006/0806/2207/0407/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1212/2001/0201/1001/2202/1002/1803/1003/1802/2642.54547.55052.55557.5May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

統一-士林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/1700.00345.4045.40-3344-0.87%
2025/03/07150.2000.0050.2013340.30%
2025/03/05150.50449.9849.60-3324-0.92%
2025/03/0400.00353.7053.70-3302-0.99%
2025/03/03153.3000.0053.0012970.34%
2025/02/2700.00153.5052.70-1286-0.35%
2025/02/2500.000.250.5050.60-0.2268-0.06%
2025/02/18049.9500.0049.3002740.00%
2025/02/13149.3500.0049.4512710.37%
2025/02/12350.7000.0049.9532681.12%
2025/02/11150.5000.0050.4012720.37%
2025/02/1000.00352.1751.60-3268-1.12%
2025/02/07149.9000.0050.5012630.38%
2025/01/14352.3300.0052.1032111.42%
2025/01/1000.00552.3051.70-5198-2.51%
2025/01/08553.3800.0051.7051842.70%
2024/12/12149.1000.0048.4011260.79%
2024/12/1100.00549.2048.65-5121-4.12%
2024/12/0600.00546.3546.20-5105-4.76%
2024/08/1600.00143.2043.20-1426-0.23%
2024/07/2300.00445.5045.55-4393-1.02%
2024/07/22446.0000.0046.5043911.02%
2024/07/19148.6000.0046.5013840.26%
2024/07/18247.23247.7548.0003460.00%
2024/07/0400.00549.2549.55-5295-1.69%
2024/07/02551.00550.8250.4002620.00%
2024/07/011049.41549.7550.2052142.33%
2024/06/28046.0500.0046.2001840.00%
2024/04/1900.00042.5042.0501630.00%
2024/04/17543.8500.0044.0051593.13%
2024/04/1500.00045.0544.5501600.00%
2024/04/09045.3000.0045.1501640.00%
2024/04/08045.4500.0045.3001650.00%
2024/04/0200.001146.9046.30-11165-6.63%
2024/03/25546.0000.0045.9051663.00%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章